Approval · Notice of Compliance 6795 · 1997
PROGRAM TABLETS 409.8 MG: Notice of Compliance 6795
Issued September 5, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 6795
- Date
- September 5, 1997
- Company
- Novartis Animal Health Canada Inc.Mississauga, Ontario, Canada
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Antiparasitic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PROGRAM TABLETS 409.8 MG | 02087367 | Cancelled Post Market |
Medicinal ingredients
- LUFENURON 409.8 MG per TAB